Admission Date:  [**2119-9-16**]              Discharge Date:   [**2119-9-27**]  Date of Birth:  [**2036-7-6**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2610**] Chief Complaint: Respiratory Distress  Major Surgical or Invasive Procedure: NA   History of Present Illness: 83y/oF Spanish-speaking with a PMH of COPD on home 3L O2, DM2, diastolic CHF, admitted with dyspnea.
Pt reports, through her daughter translating, that she has felt a heaviness in her chest for approx 1.5 week with occasional fevers, and productive cough although she has not brought up much.
She states that she received an antibiotic at her NH.
On ROS: the pt denies HA, Visual changes, Chest Pain, Nausea, Vomitting, Diarrhea, or Dysuria.
In the ED her vitals were 99.3 110 [**Numeric Identifier **] 15 100% 10L -> 95% on 4L, the pt was given Levaquin 750mg x1, Ceftriaxone 1gm x1, Tylenol 650mg PR, Prednisone 60mg PO xl, as well as neb treatments.
Past Medical History: -HTN -DM2 -CVA: bleeding aneurysm x 2, s/p clipping -CHF: diastolic ([**Hospital1 112**]: ef 75%) -COPD: FEV1 0.46, 27%; FVC 0.48, 20% -seizure d/o (further details unknown) -AS   Social History: Lives with daughter.
[**2119-9-15**] 09:55PM URINE  RBC-0 WBC-[**2-15**] BACTERIA-MANY YEAST-NONE EPI-0 [**2119-9-15**] 09:55PM URINE  BLOOD-NEG NITRITE-POS PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2119-9-15**] 09:55PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.016 [**2119-9-15**] 09:55PM URINE  GR HOLD-HOLD [**2119-9-15**] 09:55PM URINE  HOURS-RANDOM [**2119-9-15**] 10:01PM   GLUCOSE-141* LACTATE-2.0 NA+-141 K+-5.8* CL--92* TCO2-38* [**2119-9-15**] 10:15PM   PLT COUNT-237 [**2119-9-15**] 10:15PM   NEUTS-82.2* LYMPHS-10.5* MONOS-7.1 EOS-0.3 BASOS-0 [**2119-9-15**] 10:15PM   WBC-12.6*# RBC-3.22* HGB-7.1*# HCT-26.4* MCV-82 MCH-22.0*# MCHC-26.8*# RDW-16.4* [**2119-9-15**] 10:15PM   CK-MB-NotDone cTropnT-<0.01 [**2119-9-15**] 10:15PM   CK(CPK)-45 [**2119-9-15**] 10:15PM   estGFR-Using this [**2119-9-15**] 10:15PM   UREA N-21* CREAT-0.6 [**2119-9-16**] 09:21AM   PLT COUNT-187 [**2119-9-16**] 09:21AM   NEUTS-84.4* LYMPHS-9.5* MONOS-6.0 EOS-0.1 BASOS-0 [**2119-9-16**] 09:21AM   WBC-11.4* RBC-2.82* HGB-6.2* HCT-22.8* MCV-81* MCH-21.8* MCHC-26.9* RDW-16.4* [**2119-9-16**] 09:21AM   CALCIUM-8.3* PHOSPHATE-2.4* MAGNESIUM-2.0 [**2119-9-16**] 09:21AM   GLUCOSE-138* UREA N-22* CREAT-0.6 SODIUM-141 POTASSIUM-5.4* CHLORIDE-99 TOTAL CO2-40* ANION GAP-7* [**2119-9-16**] 03:50PM   POTASSIUM-5.5* [**2119-9-16**] 05:38PM   TYPE-ART PO2-87 PCO2-86* PH-7.30* TOTAL CO2-44* BASE XS-12 INTUBATED-NOT INTUBA [**2119-9-16**] 07:04PM   K+-5.5* [**2119-9-16**] 07:04PM   TYPE-ART O2 FLOW-2 PO2-61* PCO2-81* PH-7.31* TOTAL CO2-43* BASE XS-10 INTUBATED-NOT INTUBA COMMENTS-NASAL [**Last Name (un) 154**]  Brief Hospital Course: # Dyspnea: The patient presented with worsening dyspnea and increased 02 requirement from 3L to 4L in the setting of a fever, and mild leukocytosis and productive cough of 1.5 weeks duration.
The patient was continued on broad antibiotics for HCAP (Vanc/Zosyn/Levaquin).
The patient was also kept on PO Predisone at 60mg PO Daily with plans for a slow taper.
The patient remained on 3L NC and was subsequently transferred back to the floor.
A PICC line was placed to aide with antibiotic administration.
Vanc and Zosyn were continued for a 14 day course (Started on [**2119-9-17**]).
The patient received treatment for 10 days while in the hospital.
A PICC line was placed for outpatient administration of abx.
We recommend tappering prednisone as follows: decrease the dose of prednisone by 10 mg for three days and then decrease the dose again by 10 mg for another three days and so on.
The final dose of Prednisone should be 10 mg oraly daily.
With regards to albuterol and ipratropium these were administered on a regular basis.
A transfusion of two units of pRBC was performed with an increase in HCT (23 to 25).
Continued Phenytoin but her dose was doubled as her phenytoin serum level was low.
# DM: This remained stable on insulin sliding scale.
While on steroids we increased the morning and evening NPH to 6 and five units respectively.
pt will require fingerstsick glucose readings and adjustment of insulin as steroids are tapered.
The fluid status was closely monitored and she was continued on Lisinopril and B-blockers.
The patient's lasix was continued at 20 mg PO QD.
Lasix was held for one day as the patient became volume depleted.
Future monitoring of the volume status is necessary while on lasix therapy.
Medications on Admission: Medications: (From Last Discharge Summary) -Furosemide 20 mg Tablet -Pantoprazole 40 mg Tablet -Metoprolol Succinate 100 mg DAILY -Lisinopril 10 mg PO DAILY -Albuterol 90 mcg/Actuation Aerosol Inhalation Q4H -Tiotropium Bromide 18 mcg INH -Phenytoin 100 mg/4 mL Suspension Sig: One (1)  PO TID (3 times a day).
-Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
-Lidocaine 5 %(700 mg/patch) Adhesive Patch, One (1) Adhesive Patch, Medicated Topical QDAILY (): Please take  off for 12 hours each day.
-Bisacodyl 10 mg Suppository Sig: 1 PR QHS PRN -Ferrous Sulfate 325 mg PO DAILY -Pravastatin 20 mg Tablet Sig: Two (2) Tablet PO DAILY -Fluticasone 110 mcg/Actuation 4 Puff Inhalation [**Hospital1 **] -Ipratropium Bromide 0.02 % Solution Sig: 1 Q6H PRN -Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for -Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
-Prednisone 10 mg -Insulin sliding scale  Discharge Medications: 1.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q4H (every 4 hours).
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day).
Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed.
Guaifenesin 600 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO BID (2 times a day).
Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical QID (4 times a day).
Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Prednisone 10 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily): taper by 10mg q 3 days to final of 10mg QD: 30 mg started on [**9-26**] .
Vancomycin in Dextrose 1 gram/200 mL Piggyback Sig: One (1) Intravenous Q 24H (Every 24 Hours): Day 1 on [**9-17**]; to complete 14 day course.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
22. insulin sliding scale please print a copy of the inpatient sliding scale sheet   Discharge Disposition: Extended Care  Facility: [**Hospital1 599**] of [**Location (un) 55**]  Discharge Diagnosis: Chronic obstructive pulmonary disease exacurbation helath care acquired pneumonia Anemia Congestive Heart Failure   Discharge Condition: GOOD   Discharge Instructions: You were admitted with sortness of breath which was found to be caused by exacurbation of your chronic obstructive lung disease.
We gave you breathing treatments and antibiotics to help fight the infection.
